EdgarLookup

Lineage Cell Therapeutics, Inc. — POS AM Filings

15 POS AM filings on record

This page lists all POS AM filings submitted to the SEC by Lineage Cell Therapeutics, Inc. (LCTX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Lineage Cell Therapeutics, Inc. has filed 15 POS AM documents with the SEC since 2012. To view all SEC filings by Lineage Cell Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-K405 10-K405/A 10-Q 10-Q/A 10KSB 10QSB 144 25-NSE 3 3/A 4 4/A 424B1 424B3 424B5 425 5 5/A 8-A12B 8-A12G 8-K 8-K/A ARS AW CERTNYS CORRESP CT ORDER D D/A DEF 14A DEFA14A DEFR14A DEL AM DFAN14A EFFECT NT 10-K NT 10-Q POS AM PRE 14A PRER14A REGDEX RW S-2 S-2/A S-3 S-3/A S-4 S-4/A S-8 S-8 POS SC 13D SC 13D/A SC 13G SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
POS AM BIOTIME, INC POS AM 12-17-2013 0001140361-13-046541 Dec 17, 2013
POS AM BIOTIME INC POS AM #3 12-21-2012 0001140361-12-052484 Dec 21, 2012
POS AM BIOTIME INC POS AM 12-7-2012 0001140361-12-050211 Dec 7, 2012
POS AM BIOTIME, INC POS AM 11-21-2012 0001140361-12-048525 Nov 21, 2012
POS AM BIOTIME POST-EFFECTIVE AMENDMENT NO 1 FILE 333-167822 0000876343-11-000023 May 5, 2011
POS AM BIOTIME POS AM 1-7-2010 0001140361-10-001129 Jan 7, 2010
POS AM BIOTIME POS-AM NO 4_09-04-2009 0000876343-09-000060 Sep 4, 2009
POS AM BIOTIME POS AM #3 6-18-2009 0001140361-09-014912 Jun 18, 2009
POS AM POST-EFFECTIVE AMENDMENT TO FORM S-2 0000950134-05-022203 Nov 23, 2005
POS AM POST EFFECTIVE AMENDMENT 0000950134-05-020270 Nov 2, 2005
POS AM POST-EFFECTIVE AMENDMENT TO FORM S-2 0000950134-05-010722 May 24, 2005
POS AM POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-2 0000950149-04-001241 Jul 8, 2004
POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-2 0000950149-04-001114 Jun 10, 2004
POS AM AMEND. NO. 1 TO FORM S-1 0000950005-96-000313 May 15, 1996
POS AM POST-EFFECTIVE AMENDMENT TO FORM S-3 0000950005-96-000257 May 14, 1996